UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~Pursuant~~PURSUANT TO toSECTION ~~Section~~ 13 orOR 15(d) ofOF ~~the Securities Exchange Act of 1934~~THE

~~Date of Report (Date of earliest event reported):~~SECURITIES ~~March~~EXCHANGE ~~31,~~ACT ~~2016~~OF 1934

~~ACCELERA~~Date ~~INNOVATIONS,~~of ~~INC.~~Report:

(~~Exact name~~ Date of ~~registrant~~earliest asevent ~~specified in its charter~~reported)

Delaware		000-53392		26-2517763
(State or other jurisdiction of incorporation)		(Commission File No.)		(IRS Employer Identification No.)

November 15, 2016

20511 Abbey Dr. Frankfort, IL		60423
(Address of principal executive offices)		(Zip Code)

Accelera Innovations, Inc.

(~~866)~~Exact name ~~866-0758~~of registrant as specified in charter)

~~Registrant’s telephone number, including area code~~DELAWARE

~~Check the appropriate box below if the Form~~(State ~~8-K~~or ~~filing~~other isJurisdiction ~~intended to simultaneously satisfy the filing obligation~~ of ~~the~~Incorporation ~~registrant~~or ~~under any of the following provisions (see General Instruction A.2. below~~Organization):

000- 53392

20511 Abbey Drive

Frankfort, Illinois 60423

26-2517763

(Commission

File Number)

(Address of Principal

Executive Offices and zip code)

(IRS Employer

Identification No.)

(866) 920-0758

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 (b) under the Exchange Act (17 CFR 240.14a-12(b))

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~Safe Harbor ~~1.01.~~Statement ~~Entry~~under ~~into~~the aPrivate ~~Material~~Securities ~~Definitive~~Litigation ~~Agreement.~~Reform Act of 1995

~~Termination~~Information included ~~Agreement~~in ~~with~~this ~~Blaise~~Form J8-K may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). ~~Wolfrum~~This information may involve known and unknown risks, uncertainties and other factors which may cause the Company’s MDactual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Forward-looking statements, which involve assumptions and describe the Company’s future plans, strategies and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project” or the negative of these words or other variations on these words or comparable terminology. These forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that any projections included in these forward-looking statements will come to pass. The Company’s actual results could differ materially from those expressed or implied by the forward-looking statements as a result of various factors. Except as required by applicable laws, the Company undertakes no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.

~~Accelera Innovations, Inc.~~Item ~~(the “Company”), Blaise J~~4.01 ~~Wolfrum,~~Change ~~M.D.~~in ~~(the~~Registrant’s ~~“Seller”),~~Certifying ~~and Behavioral Health Care Associates, Ltd~~Accountant., an Illinois corporation (the “Behavioral”) (collectively the “Parties”), entered into a Stock Purchase Agreement dated on or about November 20, 2013, First Amendment to the Stock Purchase Agreement dated February 24, 2014, Second Amendment to the Stock Purchase Agreement dated March 18, 2014, Third Amendment to the Stock Purchase Agreement dated May 30, 2014, Fourth Amendment to the Stock Purchase Agreement dated May 31, 2015, Employment Agreement and Employee Confidentiality, Non-Circumvention and Non-Solicitation Agreement dated on or about November 20, 2013, Stock Pledge and Escrow Agreement dated on or about November 20, 2013, Stock Power Certificate dated on or about November 20, 2013, Bill of Sale dated on or about November 20, 2013, Assignment of Stock dated on or about November 20, 2013, and other written and oral agreements or understandings relating to the aforementioned agreements (hereinafter collectively referred to as the “Stock Sale Agreement”).

On November ~~March 31~~15, 2016 Accelera Innovations, Inc. (the ~~Parties~~ ~~executed~~“Company”) anotified ~~Termination~~Anton ~~Agreement~~& ~~(the~~Chia ~~“Termination~~LLP ~~Agreement~~(“Anton”), the byCompany’s ~~which~~independent registered public accounting firm, that the ~~Stock~~Company ~~Sale~~engaged ~~Agreement~~a ~~was~~new ~~terminated~~independent registered public ~~effect~~accounting asfirm ofand ~~January~~thereby 1,was ~~2016~~terminating ~~except~~its ~~for~~relationship with Anton. The decision to change independent registered public accounting firms was approved by the ~~following~~Company’s ~~Surviving~~Board ~~Obligations:~~of Directors.

~~A. The Parties agree and~~Anton’s ~~reaffirm~~reports ~~their~~on ~~previous agreement that~~ the Company’s ~~has~~financial ~~conveyed~~statements ~~and~~for ~~transferred or shall convey or transfer Seventy Thousand (70,000) Shares of Stock in~~ the ~~Company.~~two ~~The~~fiscal ~~Seller~~years ~~shall~~ended beDecember ~~fully vested in the Seventy Thousand (70~~31,~~000)~~ ~~Shares~~2014 ofand ~~Stock~~2015 ~~upon~~did ~~the~~not ~~execution~~contain ofan ~~this~~adverse ~~Agreement~~opinion byor ~~all~~disclaimer ~~Parties. The Seventy Thousand (70,000) Shares~~ of ~~Stock~~opinion ~~shall be unrestricted~~ and ~~free~~were ~~trading~~not ~~stock~~qualified ~~and free~~or ~~and~~modified ~~clear~~as ofto ~~all~~audit ~~liens,~~scope ~~security~~or ~~interests,~~accounting ~~pledges,~~principles. ~~restrictions,~~Their opinions ~~encumbrances,~~were ~~equities,~~qualified ~~claims,~~as ~~charges,~~to ~~voting~~the ~~agreements, voting~~uncertainty ~~trusts, proxies and rights~~ of ~~any~~a ~~kind,~~going ~~nature or description, except for restrictions imposed under federal securities laws~~concern.

B.During the ~~The~~ Company’s two most recent fiscal years ended December 31, at2014 ~~its sole~~and ~~cost~~2015, and ~~expense~~through November 15, ~~shall~~2016, ~~immediately~~there ~~take~~were ~~any~~no disagreements between the Company and ~~all~~Anton ~~actions~~on ~~required~~any tomatter ~~remove~~of ~~all~~accounting ~~restrictions~~principles onor ~~the~~practices, ~~Seventy~~financial ~~Thousand~~statement ~~(70~~disclosure,~~000)~~ ~~Shares~~or ofauditing ~~Stock~~scope inor ~~the Company~~procedure, ~~including~~which disagreements, ~~without~~if ~~limitation,~~not resolved to the ~~provision~~satisfaction of anAnton ~~attorney~~would ~~opinion~~have ~~letter~~caused ~~satisfactory~~it to ~~the~~make ~~Company~~a reference to the ~~extent~~subject ~~legally~~matter ~~permissible~~of the disagreements in connection with their report on the Company’s financial statements for such years. There were no reportable events (as described under ~~federal~~Item ~~securities~~304(a)(1)(v) ~~laws~~of Regulation S-K) during the Company’s two most recent fiscal years ended December 31, 2014 and 2015, or the interim period through November 15, 2016.

C. The ~~Parties agree that~~ ~~the~~ Company has ~~transferred~~provided orAnton ~~conveyed~~with ora ~~shall~~copy ~~transfer~~of ~~and~~this ~~convey~~disclosure ~~Six~~and ~~Hundred~~requested ~~Thousand~~that ~~(600,000)~~Anton ~~Shares~~furnish ~~of Stock in~~ the Company~~. The~~ ~~Seller~~with ~~shall~~a beletter ~~fully~~addressed to ~~vested~~ the ~~Six~~Securities ~~Hundred Thousand (600,000) Shares of Stock upon the execution of this Agreement by all Parties. The Six Hundred Thousand (600,000) Shares of Stock shall be free~~ and ~~clear~~Exchange ofCommission ~~all~~stating ~~liens,~~whether ~~security~~it ~~interests,~~agrees ~~pledges, restrictions, encumbrances, equities, claims, charges, voting agreements, voting trusts, proxies and rights of any kind, nature~~ or ~~description,~~disagrees ~~except~~with ~~for~~ the ~~terms~~statements ~~and~~by ~~conditions of~~ the ~~Lock-Up~~Company ~~and~~in ~~Leak-Out~~this ~~Agreement dated November 20, 2013 and restrictions~~Current ~~imposed~~Report ~~under~~on ~~federal~~Form ~~securities laws~~8-K.

DOn November 14, 2016, the Company engaged AJ Robbins CPA LLC (“AJ Robbins”) as its new independent registered public accounting firm. The engagement of AJ Robbins was approved by the Company,’s atBoard ~~its~~of Directors. During the Company’s ~~sole~~two ~~cost~~most ~~and~~recent ~~expense~~fiscal years ended December 31, ~~shall~~2014 ~~take~~and ~~any~~2015 and ~~all~~through ~~actions~~November ~~required~~15, to2016, ~~remove~~neither ~~all~~the ~~restrictions~~Company nor anyone acting on ~~the~~its ~~Six~~behalf ~~Hundred~~consulted ~~Thousand~~with AJ Robbins regarding either (~~600,000~~i) ~~Shares~~ the application of ~~Stock,~~accounting ~~including,~~principles ~~without~~to ~~limitation~~a specific transaction, either completed or proposed; or the ~~provision~~type of anaudit ~~attorney~~ opinion ~~letter~~that ~~satisfactory~~might tobe rendered on the Company’s financial statements, and no written report was provided to the Company or oral advice was provided that AJ Robbins concluded was an important factor ~~extent~~considered ~~legally~~by ~~permissible~~the ~~under~~Company ~~federal~~in ~~securities~~reaching ~~laws,~~a ~~subject~~decision as to the ~~terms~~accounting, ~~and~~auditing ~~conditions~~or offinancial reporting issue; or (ii) any matter that was the ~~Lock-Up~~subject ~~and~~of ~~Leak~~either a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-~~Out~~K) ~~Agreement~~or a reportable event (as described ~~dated~~in ~~November~~Item ~~20,~~304(a)(1)(v) ~~2013~~of Regulation S-K).

E. The transfer of Shares from the Company to Seller is irrevocable and non-refundable under any circumstance. The Parties agree that the transfer of Shares from the Company to Seller shall not be deemed to be consideration under or pursuant to the Stock Sale Agreement.2

In addition, the Seller agreed to permit the Company, at its sole cost and expense, to conduct a commercially reasonable audit of Behavioral consistent with the nature and scope of previous audits performed by the Company of Behavioral. Further, the Company agreed to file a Form 8-K with the U.S. Securities and Exchange Commission disclosing the terms of the Termination Agreement.SIGNATURES

~~The~~Pursuant to ~~foregoing~~the ~~description~~ requirements of the ~~Termination~~Securities ~~Agreement~~Exchange ~~are~~Act ~~qualified~~of in1934, ~~their~~the ~~entirety~~Registrant byhas ~~reference~~duly caused this Current Report on Form 8-K to be ~~such~~signed ~~agreements~~on ~~which~~its isbehalf ~~filed~~by asthe ~~Exhibit~~undersigned ~~10.1~~hereunto ~~hereto~~duly authorized.

Resignation and Release Agreement with Blaise J. Wolfrum, MD

	ACCELERA INNOVATIONS, INC.
	(Registrant)

Date: November 17, 2016

	By:	/s/ Geoff Thompson
		Geoff Thompson
		Chairman of Board

In conjunction with the Termination Agreement, the Company, Blaise J. Wolfrum, M.D., and Accelera Healthcare Management Service Organization, LLC (“Accelera Healthcare”) executed a Resignation and Release Agreement effective as of January 1, 2016 pursuant to which Blaise J. Wolfrum, M.D. resigned as manager and from any and all positions with Accelera Healthcare. Further, the Company and Accelera Healthcare, and any of their affiliates or other parties claiming by or through the Company or Accelera Healthcare, agreed to release and discharge Blaise J. Wolfrum, M.D., from any and all claims, actions, lawsuits, obligations, or liability, monetary or otherwise arising from or related to the Operating Agreement of Accelera Healthcare, his performance and actions as Manager of Accelera Healthcare, or any other issue or matter arising prior to or on the date of full execution of the resignation and Release Agreement. In addition, the Company and Accelera Healthcare, and any of their affiliates or other parties claiming by or through the Company or Accelera Healthcare, agreed not to make, commence, file, or assert against Blaise J. Wolfrum, M.D., any claim, lawsuit, action, or other request for relief arising from or related to the Operating Agreement of Accelera Healthcare, his performance and actions as Manager Accelera Healthcare, or any other issue or matter arising prior to or on the date of full execution of this Agreement.3

The foregoing description of the Resignation and Release Agreement are qualified in their entirety by reference to such agreements which is filed as Exhibit 10.2 hereto.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

In conjunction with the Termination Agreement, Dr. Wolfrum resigned as the President of Accelera Healthcare.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.		Description
10.1		Termination Agreement by and among Accelera Innovations, Inc., Blaise J. Wolfrum, M.D., and Behavioral Health Care Associates, Ltd. dated March 31, 2016.
10.2		Resignation and Release Agreement by and among Accelera Innovations, Inc., Blaise J. Wolfrum, M.D., and Accelera Healthcare Management Service Organization, LLC effective as of January 1, 2016.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ACCELERA INNOVATIONS, INC.
Date: April 6, 2016	By:	/s/ Geoff Thompson
		Geoff Thompson
		Chairman of Board

Filing Compare · ACCELERA INNOVATIONS, INC.